New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3
Linliu Peng,Zhao Chen,Zhe Long,Mingjie Liu,Lijing Lei,Chunrong Wang,Huirong Peng,Yuting Shi,Yun Peng,Qi Deng,Shang Wang,Guangdong Zou,Linlin Wan,Hongyu Yuan,Lang He,Yue Xie,Zhichao Tang,Na Wan,Yiqing Gong,Xuan Hou,Lu Shen,Kun Xia,Jinchen Li,Chao Chen,Rong Qiu,Thomas Klockgether,Beisha Tang,Hong Jiang
DOI: https://doi.org/10.1212/wnl.0000000000012068
IF: 9.9
2021-04-23
Neurology
Abstract:Objectives The aim of this study was to develop an appropriate parametric survival model to predict patient's age at onset (AAO) for spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) populations from mainland China. Methods We compared the efficiency and performance of 6 parametric survival analysis methods (exponential, weibull, log-gaussian, gaussian, log-logistic, and logistic) based on cytosine-adenine-guanine (CAG) repeat length at ATXN3 to predict the probability of AAO in the largest cohort of patients with SCA3/MJD. A set of evaluation criteria, including −2 log-likelihood statistic, Akaike information criterion (AIC), bayesian information criterion (BIC), Nagelkerke R-squared (Nagelkerke R^2), and Cox-Snell residual plot, were used to identify the best model. Results Among these 6 parametric survival models, the logistic model had the lowest −2 log-likelihood (6,560.12), AIC (6,566.12), and BIC (6,566.14) and the highest value of Nagelkerke R^2 (0.54), with the closest graph to the bisector Cox-Snell residual graph. Therefore, the logistic survival model was the best fit to the studied data. Using the optimal logistic survival model, we indicated the age-specific probability distribution of AAO according to the CAG repeat size and current age. Conclusions We first demonstrated that the logistic survival model provided the best fit for AAO prediction in patients with SCA3/MJD from mainland China. This optimal model can be valuable in clinical and research. However, the rigorous clinical testing and practice of other independent cohorts are needed for its clinical application. A unified model across multiethnic cohorts is worth further exploration by identifying regional differences and significant modifiers in AAO determination.
clinical neurology